JP2005508959A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508959A5
JP2005508959A5 JP2003535782A JP2003535782A JP2005508959A5 JP 2005508959 A5 JP2005508959 A5 JP 2005508959A5 JP 2003535782 A JP2003535782 A JP 2003535782A JP 2003535782 A JP2003535782 A JP 2003535782A JP 2005508959 A5 JP2005508959 A5 JP 2005508959A5
Authority
JP
Japan
Prior art keywords
mycophenolic acid
tablet
enteric
mycophenolate
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508959A (ja
Filing date
Publication date
Priority claimed from GBGB0124953.1A external-priority patent/GB0124953D0/en
Application filed filed Critical
Publication of JP2005508959A publication Critical patent/JP2005508959A/ja
Publication of JP2005508959A5 publication Critical patent/JP2005508959A5/ja
Pending legal-status Critical Current

Links

JP2003535782A 2001-10-17 2002-10-16 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 Pending JP2005508959A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0124953.1 2001-10-17
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009012781A Division JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物

Publications (2)

Publication Number Publication Date
JP2005508959A JP2005508959A (ja) 2005-04-07
JP2005508959A5 true JP2005508959A5 (https=) 2005-12-22

Family

ID=9924043

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003535782A Pending JP2005508959A (ja) 2001-10-17 2002-10-16 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物
JP2009012781A Pending JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009012781A Pending JP2009137996A (ja) 2001-10-17 2009-01-23 ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物

Country Status (31)

Country Link
US (3) US20050013859A1 (https=)
EP (1) EP1438040B2 (https=)
JP (2) JP2005508959A (https=)
KR (1) KR100671367B1 (https=)
CN (1) CN1310640C (https=)
AR (2) AR036813A1 (https=)
AT (1) ATE374023T1 (https=)
AU (1) AU2002338897B2 (https=)
BR (1) BR0213355A (https=)
CA (1) CA2460574A1 (https=)
CO (1) CO5390076A1 (https=)
CY (1) CY1107841T1 (https=)
DE (1) DE60222687T3 (https=)
DK (1) DK1438040T4 (https=)
EC (2) ECSP024341A (https=)
ES (1) ES2292819T5 (https=)
GB (1) GB0124953D0 (https=)
HU (1) HU231114B1 (https=)
IL (2) IL160968A0 (https=)
MX (1) MXPA04003636A (https=)
MY (1) MY139206A (https=)
NO (1) NO341804B1 (https=)
NZ (1) NZ532280A (https=)
PE (1) PE20030476A1 (https=)
PL (2) PL415001A1 (https=)
PT (1) PT1438040E (https=)
RU (2) RU2338528C2 (https=)
SI (1) SI1438040T2 (https=)
TW (1) TWI333861B (https=)
WO (1) WO2003032978A1 (https=)
ZA (1) ZA200401977B (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
US20060069150A1 (en) * 2004-07-20 2006-03-30 Sandor Molnar Processes for preparation of crystalline mycophenolate sodium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
WO2006086500A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Compositions and methods for treating vascular, autoimmune and inflammatory diseases
US20060235009A1 (en) 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
RU2008116578A (ru) * 2005-09-30 2009-11-10 Новартис АГ (CH) Применение ингибиторов dpp-iv для лечения аутоиммунных заболеваний и отторжения трансплантата
US8597679B2 (en) 2005-12-21 2013-12-03 Basf Se Fine-particle crosslinked polyvinylpyrrolidone as tablet disintegrant
US20090023805A1 (en) * 2006-02-13 2009-01-22 Anne Claire Marrast Method of administration
CN102083410B (zh) 2007-06-06 2013-04-17 巴斯夫欧洲公司 用于制备迅速崩解的片剂的药物制剂
KR20160083132A (ko) 2007-06-06 2016-07-11 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
MX2010001711A (es) * 2007-08-13 2010-03-11 Panacea Biotec Ltd Composiciones de liberacion extendida que comprenden micofenolato sodico y procedimientos de las mismas.
KR20100126465A (ko) * 2008-03-05 2010-12-01 파나세아 바이오테크 리미티드 미코페놀레이트를 포함하는 변형 방출 제약 조성물 및 그것의 방법
US20100010082A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011046546A1 (en) * 2009-10-13 2011-04-21 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
WO2018170022A2 (en) * 2017-03-13 2018-09-20 Okava Pharmaceuticals, Inc. Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
CA3102412A1 (en) 2018-06-06 2019-12-12 Metavant Sciences Gmbh Methods of treating subjects having diabetes with chronic kidney disease
AU2019286326A1 (en) * 2018-06-14 2020-12-10 Poxel Film-coated tablet comprising a triazine derivative for use in the treatment of diabetes
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
US12569481B2 (en) 2020-06-12 2026-03-10 Vanderbilt University Methods of treatment for gastrointestinal motility disorders
EP4248958A3 (en) * 2021-01-28 2024-01-03 Priothera SAS Methods of treatment with s1p receptor modulators
AU2021424131A1 (en) * 2021-01-28 2023-07-27 Priothera Limited Methods of treatment with s1p receptor modulators
EP4346790A4 (en) * 2021-05-26 2025-04-16 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3705946A (en) * 1971-05-25 1972-12-12 Lilly Co Eli Method of treating hyperuricemia
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
EP0670724A1 (en) * 1992-11-24 1995-09-13 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
CZ301771B6 (cs) * 1993-10-01 2010-06-16 Syntex (U.S.A.) Llc. Farmaceutický prostredek ve forme suchého granulátu obsahující mofetil mykofenolát nebo kyselinu mykofenolovou a zpusob jeho prípravy
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
EP0724441A1 (en) * 1993-10-19 1996-08-07 The Procter & Gamble Company Picosulphate dosage form
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
JP2002544167A (ja) * 1999-05-10 2002-12-24 ノバルティス アクチエンゲゼルシャフト 有機化合物
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
WO2001064931A1 (en) * 2000-02-29 2001-09-07 Biocon India Limited Manufacture and purification of mycophenolic acid
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005508959A5 (https=)
CA2348086C (en) Controlled-release pharmaceutical formulations
RU2004115332A (ru) Фармацевтические композиции, содержащие микрофенольную кислоту или соль (микофенолят)
KR101563390B1 (ko) 감마-하이드록시부티르산을 주성분으로 하는 신규 조성물
FI92904B (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
EP2085076B1 (en) Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid
JP2009545560A5 (https=)
EA023532B1 (ru) Флотирующие микрогранулы
RU99126869A (ru) Фармацевтический препарат омепразола
UA69396C2 (uk) ПЕРОРАЛЬНА ДОЗОВАНА ФАРМАЦЕВТИЧНА ФОРМА З ДИСКРЕТНИМ ВИВІЛЬНЕННЯМ ІНГІБІТОРА Н<sup>+</sup>,К<sup>+</sup>,-АТФ-АЗИ (ВАРІАНТИ) ТА СПОСІБ ЇЇ ОДЕРЖАННЯ (ВАРІАНТИ) І СПОСІБ ЛІКУВАННЯ (ВАРІАНТИ)
RU2008106220A (ru) Гастроретентивные композиции и способ их изготовления
CN101703513A (zh) 阿司匹林和氯吡格雷或其药学上可接受的盐的复方缓释制剂
RU2006139000A (ru) Диспергирующиеся таблетки деферасирокса
ITMI941262A1 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
KR20130103384A (ko) 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN101804030A (zh) 一种双氯芬酸钠微丸制剂及其制备方法
JPS59155312A (ja) 新規薬理製剤
CA2461576A1 (en) Process for the preparation of tablets comprising s-adenosylmethionine
JP3836528B2 (ja) イブプロフェン含有錠剤及びその製造法
US20110280945A1 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
JPH05255088A (ja) 抗潰瘍剤含有製剤
JPH0733659A (ja) 抗潰瘍剤含有製剤
JP2003518486A5 (https=)
JP2002518334A5 (https=)
WO2013095316A1 (en) Synergic combination comprising anti-diabetic agent